Role of the HIF‑1 signaling pathway in chronic obstructive pulmonary disease

Fu,Xiang; Zhang,Fengling

doi:10.3892/etm.2018.6785

Role of the HIF‑1 signaling pathway in chronic obstructive pulmonary disease

Authors:
- Xiang Fu
- Fengling Zhang
View Affiliations

Affiliations: Department of Respiratory Medicine, The No. 5 Hospital of Xiamen, Xiamen, Fujian 361100, P.R. China
Published online on: September 21, 2018 https://doi.org/10.3892/etm.2018.6785
Pages: 4553-4561
Copyright: © Fu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chronic obstructive pulmonary disease (COPD) is the most common cause of chronic morbidity and mortality. However, the molecular mechanisms underlying COPD remain largely unknown. The purpose of the present study was to investigate the expression patterns of hypoxia‑inducible factor 1α (HIF‑1α), vascular endothelial growth factor (VEGF), and VEGF receptor 2 (R2) in regard to the HIF‑1 signaling pathway in COPD. The expressions of HIF‑1α, VEGF and VEGFR2 were examined and quantified in the human lung tissues of 102 subjects with a defined smoking status, with or without COPD. The expressions of HIF‑1α, VEGF and VEGFR2 were observed to be increased in the lung tissues collected from smoking COPD subjects when compared with those tissues from smoking subjects without COPD and non‑smoking subjects without COPD. The expression of HIF‑1α was shown to be positively associated with the expression of VEGF and VEGFR2. In addition, increased expression of HIF‑1α, VEGF and VEGFR2 reflected the disease severity of COPD. The key findings obtained from the present study indicated that high expression of HIF‑1α, VEGF and VEGFR2 may be associated with decreased lung function and reduced quality of life, contributing to disease progression in COPD.

View Figures

View References

1	Vestbo J, Hurd SS and Rodriguez-Roisin R: The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)-why and what? Clin Respir J. 6:208–214. 2012. View Article : Google Scholar : PubMed/NCBI
2	Duvoix A, Dickens J, Haq I, Mannino D, Miller B, Tal-Singer R and Lomas DA: Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax. 68:670–676. 2013. View Article : Google Scholar : PubMed/NCBI
3	Guo Y, Zhang T, Wang Z, Yu F, Xu Q, Guo W, Wu C and He J: Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis. Medicine (Baltimore). 95:e42252016. View Article : Google Scholar : PubMed/NCBI
4	Bhatt SP and Dransfield MT: Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res. 162:237–251. 2013. View Article : Google Scholar : PubMed/NCBI
5	Rabe KF and Watz H: Chronic obstructive pulmonary disease. Lancet. 389:1931–1940. 2017. View Article : Google Scholar : PubMed/NCBI
6	Russi EW, Karrer W, Brutsche M, Eich C, Fitting JW, Frey M, Geiser T, Kuhn M, Nicod L, Quadri F, et al: Diagnosis and management of chronic obstructive pulmonary disease: The Swiss guidelines. Official guidelines of the Swiss Respiratory Society. Respiration. 85:160–174. 2013. View Article : Google Scholar : PubMed/NCBI
7	Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G, Solanes-García I, Agüero R, Feu-Collado N, et al: Differential effect of modified medical research council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD. Chest. 148:159–168. 2015. View Article : Google Scholar : PubMed/NCBI
8	Fullerton DG, Gordon SB and Calverley PM: Chronic obstructive pulmonary disease in non-smokers. Lancet. 374:1964–1966. 2009. View Article : Google Scholar : PubMed/NCBI
9	Barnes PJ: Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med. 35:71–86. 2014. View Article : Google Scholar : PubMed/NCBI
10	Zhao X, Gao S, Ren H, Sun W, Zhang H, Sun J, Yang S and Hao J: Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Cancer Res. 74:2455–2464. 2014. View Article : Google Scholar : PubMed/NCBI
11	Gui D, Li Y, Chen X, Gao D, Yang Y and Li X: HIF-1 signaling pathway involving iNOS, COX-2 and caspase-9 mediates the neuroprotection provided by erythropoietin in the retina of chronic ocular hypertension rats. Mol Med Rep. 11:1490–1496. 2015. View Article : Google Scholar : PubMed/NCBI
12	Semenza GL: Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol. 76:39–56. 2014. View Article : Google Scholar : PubMed/NCBI
13	Lee SH, Lee SH, Kim CH, Yang KS, Lee EJ, Min KH, Hur GY, Lee SH, Lee SY, Kim JH, et al: Increased expression of vascular endothelial growth factor and hypoxia inducible factor-1α in lung tissue of patients with chronic bronchitis. Clin Biochem. 47:552–559. 2014. View Article : Google Scholar : PubMed/NCBI
14	Kranenburg AR, de Boer WI, Alagappan VK, Sterk PJ and Sharma HS: Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax. 60:106–113. 2005. View Article : Google Scholar : PubMed/NCBI
15	Johannessen A, Nilsen RM, Storebø M, Gulsvik A, Eagan T and Bakke P: Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med. 188:51–59. 2013. View Article : Google Scholar : PubMed/NCBI
16	Yu WC, Fu SN, Tai EL, Yeung YC, Kwong KC, Chang Y, Tam CM and Yiu YK: Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis. 8:389–395. 2013. View Article : Google Scholar : PubMed/NCBI
17	Jones PW, Harding G, Berry P, Wiklund I, Chen WH and Leidy Kline N: Development and first validation of the COPD assessment test. Eur Respir J. 34:648–654. 2009. View Article : Google Scholar : PubMed/NCBI
18	Ma Y, Ma L, Guo Q and Zhang S: Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. J Exp Clin Cancer Res. 29:852010. View Article : Google Scholar : PubMed/NCBI
19	Salvi S: Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease. Clin Chest Med. 35:17–27. 2014. View Article : Google Scholar : PubMed/NCBI
20	Burney P, Jithoo A, Kato B, Janson C, Mannino D, Nizankowska-Mogilnicka E, Studnicka M, Tan W, Bateman E, Koçabas A, et al: Chronic obstructive pulmonary disease mortality and prevalence: The associations with smoking and poverty-a BOLD analysis. Thorax. 69:465–473. 2014. View Article : Google Scholar : PubMed/NCBI
21	Lange P, Celli B, Agustí A, Jensen Boje G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, et al: Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 373:111–122. 2015. View Article : Google Scholar : PubMed/NCBI
22	Sundar IK, Yao H and Rahman I: Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxid Redox Signal. 18:1956–1971. 2013. View Article : Google Scholar : PubMed/NCBI
23	Pelegrino NR, Tanni SE, Amaral RA, Angeleli AY, Correa C and Godoy I: Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease. Am J Med Sci. 345:440–445. 2013. View Article : Google Scholar : PubMed/NCBI
24	Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K and Tohda Y: Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med. 103:1231–1238. 2009. View Article : Google Scholar : PubMed/NCBI
25	Donaldson GC, Seemungal TA, Bhowmik A and Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 57:847–852. 2002. View Article : Google Scholar : PubMed/NCBI
26	Eisner MD, Iribarren C, Yelin EH, Sidney S, Katz PP, Ackerson L, Lathon P, Tolstykh I, Omachi T, Byl N and Blanc PD: Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease. Am J Epidemiol. 167:1090–1101. 2008. View Article : Google Scholar : PubMed/NCBI
27	Chen YR, Dai AG, Hu RC and Kong CC: The expression of hypoxia-inducible factor-1alpha and its hydroxylases in pulmonary arteries of patient with chronic obstructive pulmonary disease. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 28:234–238. 2012.(In Chinese). PubMed/NCBI
28	Nguyen LK, Cavadas MA, Scholz CC, Fitzpatrick SF, Bruning U, Cummins EP, Tambuwala MM, Manresa MC, Kholodenko BN, Taylor CT and Cheong A: A dynamic model of the hypoxia-inducible factor 1α (HIF-1α) network. J Cell Sci. 126:1454–1463. 2013. View Article : Google Scholar : PubMed/NCBI
29	Zhang L, Ge W, Hu K, Zhang Y, Li C, Xu X, He D, Zhao Z, Zhang J, Jie F, et al: Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells. Mol Biol Rep. 39:89–95. 2012. View Article : Google Scholar : PubMed/NCBI
30	Jiang Y, Wang J, Tian H, Li G, Zhu H, Liu L, Hu R and Dai A: Increased SUMO-1 expression in response to hypoxia: Interaction with HIF-1α in hypoxic pulmonary hypertension. Int J Mol Med. 36:271–281. 2015. View Article : Google Scholar : PubMed/NCBI
31	Polosukhin VV, Cates JM, Lawson WE, Milstone AP, Matafonov AG, Massion PP, Lee JW, Randell SH and Blackwell TS: Hypoxia-inducible factor-1 signalling promotes goblet cell hyperplasia in airway epithelium. J Pathol. 224:203–211. 2011. View Article : Google Scholar : PubMed/NCBI
32	Fijalkowska I, Xu W, Comhair SA, Janocha AJ, Mavrakis LA, Krishnamachary B, Zhen L, Mao T, Richter A, Erzurum SC and Tuder RM: Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells. Am J Pathol. 176:1130–1138. 2010. View Article : Google Scholar : PubMed/NCBI
33	Hosford GE and Olson DM: Effects of hyperoxia on VEGF, its receptors, and HIF-2alpha in the newborn rat lung. Am J Physiol Lung Cell Mol Physiol. 285:L161–L168. 2003. View Article : Google Scholar : PubMed/NCBI
34	Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J and Voelkel NF: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 106:1311–1319. 2000. View Article : Google Scholar : PubMed/NCBI
35	Tipoe GL and Fung ML: Expression of HIF-1alpha, VEGF and VEGF receptors in the carotid body of chronically hypoxic rat. Respir Physiol Neurobiol. 138:143–154. 2003. View Article : Google Scholar : PubMed/NCBI
36	Jiang H, Zhu Y, Xu H, Sun Y and Li Q: Activation of hypoxia-inducible factor-1alpha via nuclear factor-kappa B in rats with chronic obstructive pulmonary disease. Acta Biochim Biophys Sin (Shanghai). 42:483–488. 2010. View Article : Google Scholar : PubMed/NCBI
37	Yamaji-Kegan K, Su Q, Angelini DJ, Champion HC and Johns RA: Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol. 291:L1159–L1168. 2006. View Article : Google Scholar : PubMed/NCBI
38	Maloney JP and Gao L: Proinflammatory cytokines increase vascular endothelial growth factor expression in alveolar epithelial cells. Mediators Inflamm. 2015:3878422015. View Article : Google Scholar : PubMed/NCBI
39	McCarty G, Awad O and Loeb DM: WT1 protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia. J Biol Chem. 286:43634–43643. 2011. View Article : Google Scholar : PubMed/NCBI
40	Ioannou M, Papamichali R, Kouvaras E, Mylonis I, Vageli D, Kerenidou T, Barbanis S, Daponte A, Simos G, Gourgoulianis K and Koukoulis GK: Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma. Lung. 187:321–329. 2009. View Article : Google Scholar : PubMed/NCBI